Neumora Therapeutics, Inc. NMRA
NASDAQ · United States · Health Technology
$0.5567-0.04 (-6.63%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.23 | -0.24 | +4.2% | $0 | — | -12.1%$1.73→$1.52 |
| Q1 2026 | 2026-05-07 | -0.30 | -0.32 | +6.3% | — | — | -21.5%$2.33→$1.83 |
| Q4 2025 | 2026-03-30 | -0.35 | -0.33 | -6.1% | — | — | -16.3%$2.33→$1.95 |
| Q3 2025 | 2025-11-06 | -0.35 | -0.34 | -2.9% | — | — | -2.3%$2.62→$2.56 |
| Q1 2025 | 2025-05-12 | -0.42 | -0.38 | -10.5% | — | — | — |
| Q4 2024 | 2025-03-03 | -0.37 | -0.44 | +15.9% | — | — | — |
| Q4 2023 | 2024-03-07 | -0.71 | -0.60 | -18.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.